Annual EBITDA:
$176.36M+$13.46M(+8.26%)Summary
- As of today, PCRX annual EBITDA is $176.36 million, with the most recent change of +$13.46 million (+8.26%) on December 31, 2024.
- During the last 3 years, PCRX annual EBITDA has risen by +$14.98 million (+9.28%).
- PCRX annual EBITDA is now at all-time high.
Performance
PCRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$34.34M-$2.11M(-5.79%)Summary
- As of today, PCRX quarterly EBITDA is $34.34 million, with the most recent change of -$2.11 million (-5.79%) on September 30, 2025.
- Over the past year, PCRX quarterly EBITDA has dropped by -$7.86 million (-18.62%).
- PCRX quarterly EBITDA is now -40.72% below its all-time high of $57.94 million, reached on December 31, 2021.
Performance
PCRX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$150.92M-$7.86M(-4.95%)Summary
- As of today, PCRX TTM EBITDA is $150.92 million, with the most recent change of -$7.86 million (-4.95%) on September 30, 2025.
- Over the past year, PCRX TTM EBITDA has dropped by -$27.11 million (-15.23%).
- PCRX TTM EBITDA is now -15.23% below its all-time high of $178.03 million, reached on September 30, 2024.
Performance
PCRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PCRX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +8.3% | -18.6% | -15.2% |
| 3Y3 Years | +9.3% | -18.2% | -14.1% |
| 5Y5 Years | +219.0% | +47.1% | +149.0% |
PCRX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +9.3% | -34.5% | +20.0% | -15.2% | +1.1% |
| 5Y | 5-Year | at high | +219.0% | -40.7% | +47.1% | -15.2% | +149.0% |
| All-Time | All-Time | at high | +470.9% | -40.7% | +294.4% | -15.2% | +366.6% |
PCRX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $34.34M(-5.8%) | $150.92M(-4.9%) |
| Jun 2025 | - | $36.45M(+24.2%) | $158.78M(-7.8%) |
| Mar 2025 | - | $29.34M(-42.2%) | $172.16M(-2.4%) |
| Dec 2024 | $176.36M(+8.3%) | $50.78M(+20.3%) | $176.36M(-0.9%) |
| Sep 2024 | - | $42.20M(-15.3%) | $178.03M(+1.5%) |
| Jun 2024 | - | $49.84M(+48.6%) | $175.34M(+4.5%) |
| Mar 2024 | - | $33.54M(-36.1%) | $167.82M(+3.0%) |
| Dec 2023 | $162.90M(+0.3%) | $52.45M(+32.8%) | $162.90M(+5.0%) |
| Sep 2023 | - | $39.51M(-6.6%) | $155.09M(-1.6%) |
| Jun 2023 | - | $42.32M(+47.9%) | $157.56M(+5.5%) |
| Mar 2023 | - | $28.62M(-35.9%) | $149.28M(-8.1%) |
| Dec 2022 | $162.43M(+0.6%) | $44.65M(+6.4%) | $162.43M(-7.6%) |
| Sep 2022 | - | $41.98M(+23.3%) | $175.72M(+3.2%) |
| Jun 2022 | - | $34.04M(-18.5%) | $170.23M(-3.3%) |
| Mar 2022 | - | $41.76M(-27.9%) | $176.04M(+9.7%) |
| Dec 2021 | $161.38M(+126.0%) | $57.94M(+58.8%) | $160.44M(+20.5%) |
| Sep 2021 | - | $36.49M(-8.5%) | $133.11M(+10.9%) |
| Jun 2021 | - | $39.86M(+52.3%) | $119.97M(+51.2%) |
| Mar 2021 | - | $26.16M(-14.5%) | $79.36M(+11.1%) |
| Dec 2020 | $71.42M(+29.2%) | $30.61M(+31.1%) | $71.45M(+17.9%) |
| Sep 2020 | - | $23.35M(+3164.2%) | $60.61M(+14.7%) |
| Jun 2020 | - | -$762.00K(-104.2%) | $52.86M(-21.8%) |
| Mar 2020 | - | $18.25M(-7.7%) | $67.57M(+25.1%) |
| Dec 2019 | $55.29M(+46.5%) | $19.77M(+26.7%) | $54.02M(+6.7%) |
| Sep 2019 | - | $15.60M(+11.8%) | $50.62M(+15.5%) |
| Jun 2019 | - | $13.95M(+196.3%) | $43.84M(+11.2%) |
| Mar 2019 | - | $4.71M(-71.2%) | $39.44M(+28.7%) |
| Dec 2018 | $37.74M(+4268.5%) | $16.37M(+85.7%) | $30.64M(+15.6%) |
| Sep 2018 | - | $8.81M(-7.7%) | $26.51M(+49.4%) |
| Jun 2018 | - | $9.55M(+333.8%) | $17.75M(+2744.7%) |
| Mar 2018 | - | -$4.08M(-133.4%) | $624.00K(+110.0%) |
| Dec 2017 | $864.00K | $12.24M(>+9900.0%) | -$6.24M(+64.7%) |
| Sep 2017 | - | $49.00K(+100.6%) | -$17.67M(+50.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | -$7.58M(+30.8%) | -$35.39M(-14.0%) |
| Mar 2017 | - | -$10.95M(-1470.0%) | -$31.04M(-61.8%) |
| Dec 2016 | -$12.01M(-157.4%) | $799.00K(+104.5%) | -$19.18M(+4.0%) |
| Sep 2016 | - | -$17.66M(-447.2%) | -$19.98M(-451.1%) |
| Jun 2016 | - | -$3.23M(-454.3%) | $5.69M(-57.9%) |
| Mar 2016 | - | $911.00K(-88.6%) | $13.52M(-53.9%) |
| Dec 2015 | $20.93M(+329.8%) | - | - |
| Sep 2015 | - | $8.01M(+74.1%) | $29.32M(+29.1%) |
| Jun 2015 | - | $4.60M(-24.4%) | $22.72M(+29.0%) |
| Mar 2015 | - | $6.08M(-42.7%) | $17.61M(+261.6%) |
| Dec 2014 | $4.87M(+110.2%) | $10.63M(+655.3%) | $4.87M(+135.1%) |
| Sep 2014 | - | $1.41M(+376.4%) | -$13.88M(+48.2%) |
| Jun 2014 | - | -$509.00K(+92.4%) | -$26.77M(+27.6%) |
| Mar 2014 | - | -$6.66M(+18.0%) | -$36.98M(+22.2%) |
| Dec 2013 | -$47.54M(-8.9%) | -$8.12M(+29.3%) | -$47.54M(+11.6%) |
| Sep 2013 | - | -$11.48M(-7.1%) | -$53.80M(+5.0%) |
| Jun 2013 | - | -$10.72M(+37.7%) | -$56.61M(-10.8%) |
| Mar 2013 | - | -$17.21M(-19.7%) | -$51.11M(-17.1%) |
| Dec 2012 | -$43.65M(-37.4%) | -$14.38M(-0.7%) | -$43.63M(-10.0%) |
| Sep 2012 | - | -$14.29M(-173.7%) | -$39.66M(-19.9%) |
| Jun 2012 | - | -$5.22M(+46.4%) | -$33.08M(+6.5%) |
| Mar 2012 | - | -$9.74M(+6.5%) | -$35.38M(-11.3%) |
| Dec 2011 | -$31.77M(-73.6%) | -$10.41M(-35.2%) | -$31.77M(-22.0%) |
| Sep 2011 | - | -$7.70M(-2.4%) | -$26.03M(+18.5%) |
| Jun 2011 | - | -$7.52M(-22.6%) | -$31.95M(-10.1%) |
| Mar 2011 | - | -$6.13M(-31.2%) | -$29.03M(-9.5%) |
| Dec 2010 | -$18.30M(+25.0%) | -$4.67M(+65.7%) | -$26.50M(+6.5%) |
| Sep 2010 | - | -$13.63M(-196.5%) | -$28.33M(-42.6%) |
| Jun 2010 | - | -$4.59M(-27.5%) | -$19.86M(-30.1%) |
| Mar 2010 | - | -$3.60M(+44.6%) | -$15.26M(-30.9%) |
| Dec 2009 | -$24.40M(+40.7%) | -$6.50M(-26.1%) | -$11.66M(-126.1%) |
| Sep 2009 | - | -$5.16M | -$5.16M |
| Dec 2008 | -$41.14M(-80.2%) | - | - |
| Dec 2007 | -$22.83M | - | - |
FAQ
- What is Pacira BioSciences, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. annual EBITDA year-on-year change?
- What is Pacira BioSciences, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. quarterly EBITDA year-on-year change?
- What is Pacira BioSciences, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. TTM EBITDA year-on-year change?
What is Pacira BioSciences, Inc. annual EBITDA?
The current annual EBITDA of PCRX is $176.36M
What is the all-time high annual EBITDA for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high annual EBITDA is $176.36M
What is Pacira BioSciences, Inc. annual EBITDA year-on-year change?
Over the past year, PCRX annual EBITDA has changed by +$13.46M (+8.26%)
What is Pacira BioSciences, Inc. quarterly EBITDA?
The current quarterly EBITDA of PCRX is $34.34M
What is the all-time high quarterly EBITDA for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high quarterly EBITDA is $57.94M
What is Pacira BioSciences, Inc. quarterly EBITDA year-on-year change?
Over the past year, PCRX quarterly EBITDA has changed by -$7.86M (-18.62%)
What is Pacira BioSciences, Inc. TTM EBITDA?
The current TTM EBITDA of PCRX is $150.92M
What is the all-time high TTM EBITDA for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high TTM EBITDA is $178.03M
What is Pacira BioSciences, Inc. TTM EBITDA year-on-year change?
Over the past year, PCRX TTM EBITDA has changed by -$27.11M (-15.23%)